Turtle, C. J., Hanafi, L., Berger, C., Hudecek, M., Pender, B., Robinson, E., . . . Maloney, D. G. (2016). Immunotherapy of non-Hodgkin lymphoma with a defined ratio of CD8(+) and CD4(+) CD19-specific chimeric antigen receptor-modified T cells. Sci Transl Med.
Citação norma ChicagoTurtle, Cameron J., et al. "Immunotherapy of Non-Hodgkin Lymphoma With a Defined Ratio of CD8(+) and CD4(+) CD19-specific Chimeric Antigen Receptor-modified T Cells." Sci Transl Med 2016.
ציטוט MLATurtle, Cameron J., et al. "Immunotherapy of Non-Hodgkin Lymphoma With a Defined Ratio of CD8(+) and CD4(+) CD19-specific Chimeric Antigen Receptor-modified T Cells." Sci Transl Med 2016.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.